NCT02953275

Synergistic Effect of Vedolizumab and Pentoxifylline

Synergistic Effect of Vedolizumab and Pentoxifylline in the Management of Patients With Inflammatory Bowel Disease

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 37 (actual)
• Sponsor: University of Miami · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the synergistic effect and clinical benefits of vedolizumab and pentoxifylline in the management of patients with inflammatory bowel disease.

Conditions

• Crohn Disease

Interventions

Type	Name	Description
DRUG	vedolizumab	standard of care
DRUG	Pentoxifylline	added to vedolizumab
DRUG	placebo	added to vedolizumab

Timeline

• Start date: 2017-04-13
• Primary completion: 2019-03-18
• Completion: 2019-06-13
• First posted: 2016-11-02
• Last updated: 2019-07-11

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study